| Fingolimod alters tissue distribution and cytokine production of human and murine innate lymphoid cells A Eken, MF Yetkin, A Vural, FZ Okus, S Erdem, ZB Azizoglu, Y Haliloglu, ... Frontiers in immunology 10, 217, 2019 | 38 | 2019 |
| The role of exercise in migraine treatment E Koseoglu, MF Yetkin, F Ugur, M Bilgen J Sports Med Phys Fitness 55 (9), 1029-36, 2015 | 36 | 2015 |
| The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals? S Sen, R Karabudak, I Schiavetti, S Demir, S Ozakbas, M Tutuncu, ... Multiple sclerosis and related disorders 52, 102968, 2021 | 26 | 2021 |
| Awareness of migraine among primary care physicians in Turkey: A regional study M Gültekin, E Balci, S İsmaİLOĞULLARI, F Yetkin, R Baydemir, F Erdoğan, ... Archives of Neuropsychiatry 55 (4), 354, 2018 | 17 | 2018 |
| Monitoring interferon β treatment response with magnetic resonance spectroscopy in relapsing remitting multiple sclerosis MF Yetkin, M Mirza, H Dönmez Medicine 95 (36), e4782, 2016 | 15 | 2016 |
| Neutrophil to-lymphocyte ratio as a possible predictor of prognosis in recently diagnosed multiple sclerosis patients MF Yetkin, M Mirza Journal of Neuroimmunology 346, 577307, 2020 | 11 | 2020 |
| Pseudoephedrine-induced nonconvulsive status epilepticus S İsmailoğulları, MF Yetkin, F Erdogan, E Delibas, M Aksu, AÖ Ersoy Epilepsy & Behavior 20 (4), 739-740, 2011 | 10 | 2011 |
| Nasu hakola disease: A rare cause of dementia and cystic bone lesions, report of a new Turkish family E Köseoğlu, F Tepgec, MF Yetkin, O Uyguner, A Ekinci, Ü Abdülrezzak, ... Archives of Neuropsychiatry 55 (1), 98, 2018 | 9 | 2018 |
| Association of amyotrophic lateral sclerosis and Behcet’s disease: is there a relationship? A multi-national case series H Mrabet, A Borhani-Haghighi, E Koseoglu, M Mutlu, R Baydemir, ... Clinical rheumatology 31, 733-738, 2012 | 8 | 2012 |
| Temporal overexpression of IL‐22 and Reg3γ differentially impacts the severity of experimental autoimmune encephalomyelitis A Eken, S Erdem, Y Haliloglu, F Zehra Okus, M Cakir, M Fatih Yetkin, ... Immunology 164 (1), 73-89, 2021 | 7 | 2021 |
| The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis C Boz, S Ozakbas, M Terzi, R Karabudak, S Sevim, R Turkoglu, A Soysal, ... Neurological Sciences 44 (6), 2121-2129, 2023 | 6 | 2023 |
| The nutritional status of relapsing-remitting multiple sclerosis (RRMS) patients compared to that of healthy people: a Turkish hospital-based study T Atuk Kahraman, M Yılmaz, MF Yetkin, M Mirza Nutritional Neuroscience 25 (11), 2279-2287, 2022 | 6 | 2022 |
| Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide MF Yetkin, NA Yetkin, M Akcakoyunlu, M Mirza Neurological Sciences 42, 1661-1664, 2021 | 6 | 2021 |
| Efficacy and tolerability of interferon gamma in treatment of friedreich’s ataxia: Retrospective study MF Yetkin, M Gültekin Archives of Neuropsychiatry 57 (4), 270, 2020 | 5 | 2020 |
| The effects of incontinence on functionality, disability, and quality of life in male and female patients with multiple sclerosis H Abakay, H Doğan, MF Yetkin, GÜÇ Ayşe, HT Çaliş, MD Caltekin Multiple Sclerosis and Related Disorders 66, 104010, 2022 | 4 | 2022 |
| Positive effects of ocrelizumab in patients with familial mediterranean fever and coexistent multiple sclerosis CF Demir, F Balgetir, Ö Ethemoğlu, D Aksoy, F Aktaş, SS Koca, MF Yetkin, ... Archives of Rheumatology 36 (2), 219, 2021 | 3 | 2021 |
| Atypical cause of abducens paralysis: a case report H Sacmaci, M Mirza, MF Yetkin, AO Ersoy, EG Baldane Journal of Neurology Research 3 (6), 181-183, 2014 | 3 | 2014 |
| A rare entity in ED: posterior reversible encephalopathy syndrome. MF Yetkin, O Salt, P Durukan, FF Erdogan, S Ozkan The American Journal of Emergency Medicine 30 (9), 2099. e1-3, 2012 | 3 | 2012 |
| Re-examining the characteristics of pediatric multiple sclerosis in the era of antibody-associated demyelinating syndromes Ü Yılmaz, K Gücüyener, M Yavuz, İ Öncel, M Canpolat, S Saltık, O Ünver, ... European Journal of Paediatric Neurology 41, 8-18, 2022 | 2 | 2022 |
| Clinical findings, etiological factors, and prognosis markers in status epilepticus: a university hospital experience MF Göl, FF Erdoğan, MF Yetkin, ÖF Bolattürk Neurological Research 44 (4), 371-378, 2022 | 2 | 2022 |
ahmet ekenPostdocseattlechildrens.org üzerinde doğrulanmış e-posta adresine sahip
